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Abstract: COPD is considered a complex disease and global problem that is predicted to be 
the third most common cause of death by 2030. While managing this chronic condition, primary 
health care practitioners are faced with the ongoing challenge of achieving good quality of life 
and overall “wellness” for those affected. As such, a practical tool for monitoring quality of life 
in a clinical setting is required. However, due to the wide variety of general and disease-specific 
tools from which to choose, primary health care practitioners are given minimal guidance as 
to which tool may be most appropriate. To address these challenges, the International Primary 
Care Respiratory Group (IPCRG) proposed the creation of a user’s guide for primary health 
care practitioners to assess “wellness” in COPD patients in an everyday clinical setting. This 
short report outlines the process by which the IPCRG Users’ Guide to COPD “Wellness” Tools 
was developed. It also describes why this guide has the potential to be of great value in guiding 
primary health care practitioners to improve patient wellness.
Keywords: wellness, quality of life, primary care, instrument
Introduction
COPD is considered a complex disease that, according to the World Health  Organization, 
is one of the most prevalent diseases worldwide and is predicted to be the third most 
common cause of death by 2030.1 As with other chronic diseases, one of the main goals 
in managing COPD is achieving a good quality of life and overall “ wellness” for those 
affected.2 In achieving and maintaining “wellness,” primary health care practitioners are 
faced with the challenge of choosing from appropriate tools that easily and effectively 
assess the severity of the disease and measure its effect on improving the patient’s 
overall quality of life.3,4 However, primary health care practitioners must choose from a 
wide variety of the available general and disease-specific tools, while receiving minimal 
guidance as to which tool may be most appropriate.3 To address these challenges, the 
International Primary Care Respiratory Group (IPCRG) recently proposed the creation 
of a user’s guide for primary health care practitioners to assess “wellness” in COPD 
patients in an everyday clinical setting. The IPCRG has a special focus on research, 
management, and education in respiratory diseases in primary care. At the request of 
the Research Subcommittee of the IPCRG, the Family Physicians Airways Group of 
Canada (FPAGC), an IPCRG member organization, accepted the task on IPCRG’s 
behalf. This short report outlines the development process of the IPCRG Users’ Guide 
to COPD “Wellness” Tools and describes why the guide has the potential to be of great 
value in guiding primary health care practitioners to improve patient wellness.
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To date, COPD has been monitored mainly by lung 
 function parameters that only weakly reflect patient 
wellness.5,6 To address this concern, there have been sev-
eral recent reviews of tools used to evaluate the wellness of 
COPD patients.3,7–11 However, the tools evaluated address 
specific aspects of the condition, such as breathlessness in 
advanced cases of respiratory diseases or the setting of treat-
ment centers.10,11 Furthermore, some tools are broader than 
others in the aspects they address, which may complicate the 
decision-making process for primary health care practitioners 
when selecting appropriate tools.7
In 2005, Fitzpatrick and colleagues performed a systematic 
review of health-related measures for a number of common 
chronic diseases, including COPD.3 They divided relevant 
health outcome tools into two groups: (1) generic (applicable 
to several diseases or populations) and (2) disease-specific 
(measuring health in only one condition), such as for COPD. 
For the purpose of our project, focus was on disease-specific 
tools, as they “may have greater clinical appeal due to their 
specificity of content, and associated increased responsive-
ness to specific changes in condition.”3 Fitzpatrick and 
 colleagues identified key criteria for assessing the quality 
of tools and selecting appropriate outcome measures, which 
included: validity, reliability, responsiveness, precision, 
acceptability, and feasibility. Using the available evidence, 
they provided useful guidance to primary health care prac-
titioners to inform them of the range of tools available, rela-
tive to their setting.3 We built on and refined  Fitzpatrick’s 
criteria to create a customized guide for the selection of the 
best disease-specific assessment tool for managing wellness 
in COPD in a primary care setting.
Methods
To get a sense of the number, type, and quality of tools cur-
rently available internationally to primary health care prac-
titioners managing patients with COPD, a comprehensive, 
systematic search was performed. Our search reviewed the 
English language literature published up to 2010.
Searches were conducted in the following databases: 
MEDLINE®, Embase, PubMed®, PsycINFO®, CINAHL®, 
Health and Psychosocial Instruments, The Medical 
 Algorithms Project, The Cochrane Library, Science Direct, 
and ProQuest Dissertations and Theses. This list includes 
databases not searched in previous reviews.3 The search 
of these databases combined both controlled vocabulary 
and keyword terms (when appropriate) relating to the fol-
lowing core concepts: (1) chronic obstructive pulmonary 
disease, (2) measurement instruments (eg, questionnaires, 
evaluations, assessments, tests, measurements, health status 
indicators, and severity of illness indices), and (3) wellness 
(eg, quality of life). Additional articles, subsequently identi-
fied from references cited in the included articles, were also 
included. Furthermore, a Google search helped identify 
additional resources, as well as relevant gray literature. In this 
case, no date or language restrictions were applied. Articles 
published prior to 1995, animal studies, and studies published 
in languages other than English were excluded.
The results from each database were imported into a 
RefWorks database,(Refworks version 2.0, Refworks-Cos 
Bethesda, USA), where duplicate articles were removed. 
(Further information on the detailed search strategies 
employed and results can be obtained from the corresponding 
author.) The summary of results is presented in Table 1.
A form of “rapid appraisal” was performed by two 
 independent researchers, whereby the titles and abstracts of the 
selected articles were scanned and reviewed for relevance, and a 
list of tools that combined or discussed aspects of “COPD” and 
“wellness” was identified. In  addition, the quality of the articles 
was assessed, with those that failed to meet a predetermined set 
of inclusion criteria culled from the database. Articles that (1) 
were peer-reviewed, (2)  provided empirical evidence of mea-
surement properties, and (3) were relevant to a primary care 
setting were included. Editorials/Commentaries and articles 
lacking authority and/or currency were excluded.
A logic chart was constructed to pool selected tools 
according to their purpose and approach. Overall, 1825 articles 
relating to 84 COPD-specific tools were identified. Of those 
84 tools, 42 were associated with patient-related health 
 outcomes or “wellness.”
Table 1 summary of results
Database Initial results Final resultsa
MEDLINE® 1 1657 –
MEDLINE 2 (refined search) 385 377
Embase 1 46 –






The Medical Algorithms Project 165 165
The Cochrane Library 74 74
science Direct 328 317
ProQuest Dissertations and Theses 80 80
Total 3554 1825
Note: aWith duplicates and non-English articles removed.
Abbreviations: CINAHL, Cumulative Index to Nursing and Allied Health 
Literature; HaPI, Health and Psychosocial Instruments.
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1825  articles 





tools 20 disease 
severity
Final 9 COPD wellness tools
for Users’ Guide 
22 “other” 
tools
Figure 1 summary of tool selection process.
Due to the wide range of articles employing a variety 
of quantitative and qualitative methods, the members of the 
IPCRG Research Subcommittee were invited to comment 
on the evaluation criteria and rank their preferred tools from 
the health outcomes/wellness group. When evaluating and 
ranking the tools, they were asked to consider supporting 
evidence from the research literature, as well as their own 
clinical and research experience. Seven of the twelve sub-
committee members provided feedback, with one declaring 
a conflict of interest.
Results
Tools that received three or more votes from the participat-
ing IPCRG Research Subcommittee members were selected 
for further assessment. This resulted in the identification 
of nine disease-specific tools that assess various aspects 
of “ wellness”: (1) Airways Questionnaire, (2) Breathing 
Problems Questionnaire – Short, (3) COPD Activity Rating 
Scale, (4) COPD Assessment Test (CAT), (5) Clinical COPD 
Questionnaire (CCQ), (6) Chronic Respiratory Disease Ques-
tionnaire (CRQ), (7) Medical Research Council, Dyspnoea, 
(8) 10 Item Respiratory Illness Questionnaire –  Monitoring, 
and (9) St George’s Respiratory Disease Questionnaire 
(SGRQ).12–23 Figure 1 illustrates the tool selection process.
Given the feedback provided by the IPCRG Research 
Subcommittee, changes were made to the original evaluation 
criteria derived from Fitzpatrick and colleagues.3 They were 
expanded to include the following six categories: (1) validity/
reliability, (2) responsiveness, (3) applicability to a primary 
care population, (4) practicality/ease of administration, 
(5) testing in practice, and (6) other language versions.
The comments and rankings from the IPCRG Research 
Subcommittee and the supporting evidence from the identi-
fied literature relating to each of the nine tools were used 
to evaluate each tool, using the six newly established and 
refined evaluation criteria. Once all the supporting evidence 
had been evaluated, it was transferred into a spreadsheet 
and distributed to the IPCRG Research Subcommittee for 
a second round of comments and feedback. Once reviewed 
and validated by the subcommittee, the supporting evidence 
spreadsheet was translated into an assessment grid, using 
a simple and effective visual ranking scale (Table 2). This 
visual ranking scale uses a display of five different color-
coded smiling/sad faces used to rank each of the nine tools, 
according to the six criteria. The five ranking possibilities 
include: (1) very poor, (2) not good enough (if this criterion 
is important), (3) good enough, (4) recommended, and 
(5) highly recommended. This visual ranking scale was 
patterned after a previously used system that successfully 
provided resources for asthma control tools.24 Full details 
for each tool, including tool description and limitations, as 
well as directions on where to find each tool and obtain user 
permission, are available in the IPCRG Users’ Guide to 
COPD “ Wellness” Tools (Appendix).25
Discussion
The variety of COPD measurement tools identified in the 
 literature suggests that there are important differences between 
the tools, with no one tool meeting all requirements.6,10,11 This 
is largely due to each tool’s inherent design and purpose. We 
assessed each tool from the vantage point of patient wellness 
during clinical care in a primary care setting. We were also 
mindful of the need for “ appropriateness” (see Fitzpatrick 
et al3), whereby the tool is acceptable to health care practi-
tioners and patients.3
Therefore, for a tool to rank high on our visual ranking 
scale, it had to be disease specific and it needed to provide 
satisfactory evidence relating to its psychometric qualities 
(criteria 1 and 2). It also had to have a proven record of suc-
cessful use, if not in primary care, then at least in ambulatory 
care in a clinical setting (criteria 3 and 5). Furthermore, it 
had to be very easy to administer and interpret, as well as 
inexpensive (criteria 4). While our search was conducted 
for English-language articles, the international members of 
the IPCRG Research Subcommittee noted the availability of 
tools described in other languages as well (criteria 6).
Of the top nine tools discussed in the Users’ Guide, the 
CCQ scored well on all criteria for suitability for use in 
primary care.17,18 Its main benefits are that it is easy to use 
and it can be completed in approximately 2 minutes by the 
patient. The CCQ is available in more than 52 languages (an 
ongoing process) and it addresses common outcomes, such 
as mental status. The CAT also scored well, even though it 
was introduced relatively recently, in 2009.15,16 The CAT is 
a simple and straightforward questionnaire that addresses 
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Table 2 Visual ranking scale
Very poor Not good enough, if this  
criterion is important
Good enough Recommended Highly  
recommended
a range of issues related to COPD when assisting primary 
health care practitioners in assessing overall patient wellbe-
ing and quality of life. Although we lack sufficient data to 
assess CAT’s responsiveness over time, its main benefits are 
that it has been designed specifically for use in the primary 
care clinical setting, is not time consuming, and is already 
available in many languages. Ongoing testing may show that 
it is among the most appropriate.
Two of the oldest and most widely used tools, the CRQ 
and the SGRQ, have been extensively used, resulting in 
some familiarity, especially in the clinical trial setting.19,20,23 
 However, despite their longevity and being ranked highly in 
the assessment grid, both have limitations: the CRQ has limited 
availability in languages other than English and the SGRQ is 
long and difficult to administer in primary care populations.
Very few articles addressed the issue of the “ceiling” 
or “basement” limitations of the tools. These terms refer 
to the ability of the tool to continue to measure changes in 
health status at the extremes of health. For example, if a 
patient scores a zero for health status on a tool (the basement 
score for that tool) but then clinically deteriorates, the tool 
cannot capture that deterioration. Therefore, that tool has a 
basement limitation. It may still be very useful in mild or 
moderately severe COPD patients but not in severe or very 
severe patients. Furthermore, the construction of most tools 
did not account for responsiveness to changes over time. 
Although we did not include it in the ranking criteria, some 
of the tools are not tested for use following an exacerbation 
and this may be important sometimes.
A weakness of our approach may be the omission, albeit 
by design, of generic health outcome tools, such as the 
Short-Form Health Survey questionnaire or the Sickness 
Impact Profile scale. These tools could add value, as they 
allow comparison with other conditions outside COPD.26,27 
If health care practitioners are planning to compare well-
ness across a series of diseases, they might use these tools 
preferentially, but the scoring system makes comparisons 
difficult. Conversely, because these tools are general health 
status and quality of life instruments, their use may be of 
limited value for COPD, as they do not provide disease-
specific information.
As stated by Fitzpatrick and colleagues, “although there 
are relatively clear cut and widely agreed criteria to assess 
measurement properties of instruments, there are no clear-
cut explicit criteria for how to weigh the balance of evidence 
for instruments comparatively.”3 In our case, each tool was 
considered in detail by the IPCRG Research Subcommittee, 
using their practitioner/practical judgment and experience as 
practicing clinicians and researchers. Therefore, we believe 
the “consensus” approach employed by the IPCRG Research 
Subcommittee was a realistic alternative to formal evalua-
tion by template.
We had a moderate response from the collaborators. One 
of the collaborators declared a potential conflict of interest and 
did not provide scores, although that individual did comment 
on the findings and the analysis. Others were also involved in 
the development of some of the highly ranked tools. Some of 
the articles suggest multiple variations of a tool, thus it was 
difficult in some articles to determine which version was 
being tested (eg, the Breathing Problems Questionnaire (BPQ) 
and its short form).13 Furthermore, the identification of tools 
published in languages other than English was limited, due to 
the margins of our initial search strategy. However, the IPCRG 
Research Subcommittee participants did consider that many 
of the articles included websites that provided supporting 
information on the availability of articles published in other 
languages (eg, the CCQ and the CAT).
One of the strengths of this review is that we performed 
an extensive, targeted search of more databases and resources 
than previous investigations with a similar objective.3 Our 
search also included tools that were developed after the 
aforementioned studies were published.3 Furthermore, we 
did not confine ourselves to just one aspect or symptom 
(eg, dyspnea), as is the case in other reviews.10,11 In this study, 
we addressed relevance to clinical primary care settings and 
focused on and refined key criteria identified by Fitzpatrick 
and colleagues as being critical in assessing the quality and 
appropriateness of these tools.3 In addition, we presented 
each tool in a simple way, to facilitate practitioner choice. 
Because most COPD cases are managed in primary care 
facilities, such a review of the existing tools was  necessary, 
as was the resulting guide. Furthermore, our review of the 
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existing tools may be of great use to those undertaking 
research in this area.
To follow up on this study, we propose that future work 
review tools that assess the severity of disease/clinical 
aspects of COPD in primary care and measure or predict 
associated features, such as depression and other related 
comorbidities. We also recommend that a repeat review be 
undertaken in 5–8 years, by which time some of the more 
recently introduced instruments (eg, the CAT) will have 
undergone further evaluation and results will have been 
formally disseminated.
Conclusion
We have identified useful, high-quality tools relevant to the 
IPCRG initiative to create the IPCRG Users’ Guide to COPD 
“Wellness” Tools.25 It is our intention to provide suggestions, 
not recommendations, on tools. With this new, customized 
guide, we offer our analysis of what could be considered 
and how these tools perform against a set of refined criteria 
for use in a primary care setting. We have concentrated on 
“wellness,” placing the patient ahead of the disease, which is 
increasingly becoming a desirable health outcome measure 
for governments and policy makers. Above all, we provide 
valuable assistance to primary health care practitioners in 
choosing the right tools for use in the management of patients 
with COPD.
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Appendix
IPCRG users’ guide to COPD  
“wellness” tools
As well as being a lung disease, chronic obstructive pulmo-
nary disease (COPD) is an illness with complications that 
are experienced in different ways by patients. There are over 
80 tools that have been developed to measure different aspects 
of COPD. This users’ guide reviews nine of the more than 
42 tools that measure the illness or wellness experience of 
the patient with COPD. It includes tools that measure health 
status or quality of life as well as tools that measure COPD 
features such as dyspnoea and breathing problems.
It has been produced by the International Primary Care 
Respiratory Group (IPCRG) as a practical guide for healthcare 
professionals working in their everyday clinical practice rather 
than for academic research use. Another guide which is cur-
rently in preparation contains the tools for assessing the disease 
severity and the third guide in the series will contain tools that 
measure associated features such as depression in COPD.
In the “Wellness in COPD” tool table/grid (Figure A1), 
there are nine tools named on the left that we, as international 
primary care clinicians, judged likely to be most useful in 
routine management of our patients with COPD. Each of the 
vertical columns refers to a desirable criterion for choosing a 
wellness tool for use in primary care. How each tool performs 
for that criterion is shown by the “smiley face” in that square. 
(The key for the faces is given above the grid.)
These criteria are:
1. Validity/reliability: Does this tool have face and content 
validity – has it been shown to actually measure what it 
is designed to measure? Is it sufficiently reliable?
2. Responsive: Is it adequately responsive to changes in the 
patient’s condition – does it indicate deterioration when 
the patient’s condition deteriorates clinically?
3. Primary care population: Is it applicable to a primary 
care population that includes people with the full range 
of mild to very severe COPD?
4. Practical/easy to administer: Is it practical for daily 
clinical assessment? Does it have scores that are easy 
to use for reassessment in follow-up? Is it easy to use 
by interview or telephone? Can it be self-completed in 
the waiting room, by post or e-mail? Is it sufficiently 
economical of time to be used in daily practice?
5. Tested in Practice: Have the IPCRG authors of this 
review used the tools in their practice – what was their 
experience? Is it applicable in daily primary care clinical 
practice? Is it easy to complete within a routine primary 
care consultation?
6. Other languages: Has it been translated and validated 
in other languages? Is it easy for busy clinicians to find 
those translations in websites?
Time to complete the tools was considered extremely 
important, and has been taken into consideration and incor-
porated in criterion four.
Which tool to select?
Depending on which criterion is most important for your 
particular need at the time of choosing, the guide will assist 
your choice. We did not weight these criteria but you could 
do that. You are advised to read the notes at the bottom of the 
table before choosing your tool. With this guide our intention 
is to give suggestions but not recommendations on tools. The 
purpose is to offer the reader our analysis of what could be 
considered by a practising clinician, and of how the tools 
perform against a set of criteria.
In the notes on each of the tools provided on pages 7–10, 
there is information on where to obtain the tools and condi-
tions for using them.
For further information, please see: http://www.theipcrg.
org/resources/resources_copd.php.
Tool description and limitations
Airways questionnaire (AQ20)
Correlates well with SGRQ and has only 20 items (yes/no). 
Short and easy to complete in 2 minutes. Useful in a clinical 
setting. Self-administered. Responds to changes, less dis-
criminating in mild COPD. Spanish and Japanese versions 
available. High score indicating poor QOL.
Where you can get this tool
Professor Paul Jones, Professor of Respiratory Medicine, 
Head of Division of Clinical Sciences, St George’s  University 
of London. Email: pjones@sgul.ac.uk. See also: Yvonne 
Forde, Academic Secretary, Cardiac and Vascular Sciences, 
St George’s University of London. Email: yforde@sgul.ac.uk.
Cost/conditions of use
Permission must be obtained from the authors.
For more information, see American Thoracic Society at: 
http://qol.thoracic.org/sections/instruments/ae/pages/air-
quest.html.
Breathing problems questionnaire- 
short (BPQ-S)
Short form of the BPQ. Not COPD specific. Self- administered, 
used in mild to moderate COPD. The BPQ-S is more 
 discriminating for COPD than the longer form.
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Figure A1 IPCRG Users’ Guide to COPD Wellness Tools.25 
Notes: All of the tools reported above need no training or equipment to complete. some questionnaires require you to request permission before you use them, and some 
may be subject to charges. Unless specified, please contact the authors if you wish to use any of these tools in your routine practice or for research. We have provided email 
addresses correct at the time of printing.
Where you can get this tool
ME Hyland at: mhyland@plymouth.ac.uk. For a direct 




Permission must be obtained from the authors.
COPD activity rating scale (CARS)
Measures life-related activities in COPD. Validity and reli-
ability tested but discriminating power not tested. 4 factors 
(self-care, domestic activities, outdoor activities and social 
interaction) with 12 items. Easy three-point scale. Limited 
literature/studies available. Higher scores indicate less 
impairment.
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Where you can get this tool
Michiko Morimoto, Faculty of Health Science, Okayama 
University Medical School, 5-2-1 Sikata-cho  Okayama-shi, 
Okayama 700-8558,  Japan.  Email :  mmichiko@
md.okayama-u.ac.jp.
Cost/conditions of use
Permission must be obtained from the authors.
For more information, see American Thoracic Society at: 
http://qol.thoracic.org/sections/instruments/ae/pages/cars.
html.
COPD assessment test (CAT)
Short, simple questionnaire for monitoring long-term follow-
up of COPD. Aimed at primary care practice. Validated in 
3 international studies. 8 items, six-point scale, responds to 
exacerbations. Self-administered. Covers a wide range of 
symptoms. Not been widely used yet as only published in 
2009. Available in many translations, although not all vali-
dated. Total score can be calculated on the website. Higher 
scores represent worse health.
Where you can get this tool 
http://www.catestonline.org/.
Cost/conditions of use
Free for use by professionals and patients in daily clinical 
practice. It requires permission if organisations wish to use 
it for academic or commercial use or other professional 
reasons.
Clinical COPD questionnaire (CCQ)
Well validated and reliable. Responds to stopping smoking 
and detects mild from moderate and severe states. Measures 
functional and mental capacities as well as symptoms. 
 Specific to COPD, as it measures COPD-related health status. 
Self-administered in daily practice. 10 items on previous 
week’s symptoms are easy to apply. Also available in a 24 h 
version. Practical and widely used. More than 53 translations: 
not all are validated. Higher scores represent worse health.
Where you can get this tool
http://www.ccq.nl.
Cost/conditions of use
The use of the questionnaire in daily clinical practice is free 
of charge. Copyright: not to be altered, sold, translated, and 
used in international research without the approval of the 
author.
Chronic respiratory disease 
questionnaire (CRQ)
Well validated and reliable in testing. Responds to changes 
over time and long-term use as well as changes in condition 
after Emergency Department treatment of exacerbations. 
20 items, 4 domains: Dyspnoea, fatigue, emotional func-
tion, mastery. Has been used by interviewer, telephone or 
self-administered. Many translations. Higher scores indicate 
better health-related quality of life.
Where you can get this tool
Contact for all matters relating to the CRQ is Mr Sunita 
Asrani: Email: asranis@mcmaster.ca.
Cost/conditions of use
Permission must be obtained from the authors.
For more information and to request permission and use: 
http://milo.mcmaster.ca/questionnaires/qol-request.
Medical research council, dyspnoea 
(MRC-D)
Widely used to assess how symptom (dyspnoea) limits activi-
ties of daily living. Well validated. Five simple items but 
ONLY measures dyspnoea, not other outcomes. Portuguese 
version validated in Brazil.
Where you can get this tool
For online access, visit: http://www.nice.org.uk/usingguid 
ance/commissioningguides/pulmonaryrehabilitationservice 
forpatientswithcopd/mrc_dyspnoea_scale.jsp. Since this is 




10 item respiratory illness questionnaire- 
monitoring (RIQ-MON10)
A reduced tool from the 55 item QoL RIQ tool. Well-
 validated against SF-36 and MRC scales. Sensitive to change 
in stable and improving mild to moderate patients. 2 factors 
(physical + emotional complaints and physical + social 
limitations) five items each. Not COPD specific. Tested in 
primary care.
Where you can get this tool
JE Jacobs. Radboud University Medical Centre, 114 IQ 
 healthcare, PO Box 9101, 6500 HB Nijmegen, The  Netherlands. 
Email: j.jacobs@iq.umcn.nl.
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Cost/conditions of use
Permission should be obtained from the authors.
st George’s respiratory disease 
questionnaire (SGRQ)
The most widely used quality-of-life instrument in the 
literature especially the “symptoms” domain that can be 
used alone. Compares to the AQ20 and CRQ. A gold  standard 
but long, not simple enough for daily use. It takes 8–10 
minutes to be completed. Scores are calculated for three 
domains: symptoms, activity and impact (psychosocial), and 
also for total score. 
Telephone or self-administered. Sensitive to changes 
in the patient’s condition. Many translations. Not COPD 
specific. Scores range from 0 to 100, with higher scores 
indicating poor health.
Where you can get this tool (and the spreadsheet 
needed to calculate the score)
Professor Paul Jones, Professor of Respiratory Medicine, 
Division of Physiological Medicine, St George’s Hospital 
Medical School, London SW17 0RE, United Kingdom 
Email: pjones@sghms.ac.uk. See also: Yvonne Forde, 
Academic Secretary, Cardiac and Vascular Sciences, 
St George’s University of London. Email: yforde@sgul.ac.uk. 
For direct access, visit: http://www.healthstatus.sgul.ac.uk.
Cost/conditions of use
No cost for use. Copyrighted, permission required. For more 
information, see American Thoracic Society at: http://qol.
thoracic.org/sections/instruments/pt/pages/george.html.
Licensed under Creative Commons Attribution-No 
Derivative Works Licence. http://creativecommons.org/
licenses/by-nd/3.0/.
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